Literature DB >> 18472849

Interleukin-6 and interleukin-6 receptor secretion by chronic lymphatic leukaemia and normal B lymphocytes: effect of PMA and PWM.

I Drucker1, A Klajman, M Revel, Y Manor, S Ben-Efraim, D Novick.   

Abstract

Interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R) were detected in supernatants of cultures of B chronic lymphatic leukaemia (CLL) lymphocytes. Phorbol-12-myristate 13 acetate (PMA) caused a decrease in the levels of IL-6 in 14 out of 16 cultures and an increase in levels of sIL6R in all 15 cases. The effect of pokeweed mitogen (PWM) was variable and not significant. The levels of IL-6 were below the detection limit (60 pg/ml) in sera of 13 CLL patients whereas sIL-6R was detected (13 ng/ml to 97 ng/ml) in the 13 sera. IL6 was not detected in cultures of unstimulated or stimulated with PMA or PWM normal human B cells. Levels of sIL-6R were minimal in cultures of normal B lymphocytes and were increased in PMA stimulated cultures. The results are consistent with the view that B-CLL cells produce spontaneously IL-6 which could act in an autocrine fashion to cause shedding of surface IL-6R and account for the correlation found between serum levels of sIL-6R and B-CLL lymphocyte numbers. The fall in levels of IL-6 in PMA stimulated CLL cultures might express masking or degradation of IL-6 after combination with the receptor.

Entities:  

Year:  1997        PMID: 18472849      PMCID: PMC2365853          DOI: 10.1080/09629359791857

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  23 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.

Authors:  P Rieckmann; F D'Alessandro; R P Nordan; A S Fauci; J H Kehrl
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

3.  Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding.

Authors:  D Novick; H Engelmann; M Revel; O Leitner; M Rubinstein
Journal:  Hybridoma       Date:  1991-02

4.  Appearance of the T-cell marker CD8 on B chronic lymphatic leukemia cells in long-term cultures.

Authors:  R Farkas; S Ben-Efraim; Y Manor; I Zan-Bar; A Klajman
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody.

Authors:  D Novick; L M Shulman; L Chen; M Revel
Journal:  Cytokine       Date:  1992-01       Impact factor: 3.861

Review 6.  IL-6 receptor and mechanism of signal transduction.

Authors:  T Kishimoto; S Akira; T Taga
Journal:  Int J Immunopharmacol       Date:  1992-04

7.  Differential effects of low and high concentrations of interleukin 6 on human B cells.

Authors:  Y Levy; J P Fermand; J C Brouet
Journal:  Eur J Immunol       Date:  1990-11       Impact factor: 5.532

8.  The soluble interleukin-6 receptor is generated by shedding.

Authors:  J Müllberg; H Schooltink; T Stoyan; M Günther; L Graeve; G Buse; A Mackiewicz; P C Heinrich; S Rose-John
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

9.  Soluble interferon-alpha receptor molecules are present in body fluids.

Authors:  D Novick; B Cohen; M Rubinstein
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

10.  Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication.

Authors:  S Navarro; N Debili; J P Le Couedic; B Klein; J Breton-Gorius; J Doly; W Vainchenker
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.